Cargando…
Development of a PHBV nanoparticle as a peptide vehicle for NOD1 activation
NOD1 is an intracellular receptor that, when activated, induces gene expression of pro-inflammatory factors promoting macrophages and neutrophils recruitment at the infection site. However, iE-DAP, the dipeptide agonist that promotes this receptor's activation, cannot permeate cell membranes. T...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174487/ https://www.ncbi.nlm.nih.gov/pubmed/34060399 http://dx.doi.org/10.1080/10717544.2021.1923862 |
_version_ | 1783702920257077248 |
---|---|
author | Cabaña-Brunod, Mauricio Herrera, Pablo A. Márquez-Miranda, Valeria Llancalahuen, Felipe M. Duarte, Yorley González-Nilo, Danilo Fuentes, Juan A. Vilos, Cristián Velásquez, Luis Otero, Carolina |
author_facet | Cabaña-Brunod, Mauricio Herrera, Pablo A. Márquez-Miranda, Valeria Llancalahuen, Felipe M. Duarte, Yorley González-Nilo, Danilo Fuentes, Juan A. Vilos, Cristián Velásquez, Luis Otero, Carolina |
author_sort | Cabaña-Brunod, Mauricio |
collection | PubMed |
description | NOD1 is an intracellular receptor that, when activated, induces gene expression of pro-inflammatory factors promoting macrophages and neutrophils recruitment at the infection site. However, iE-DAP, the dipeptide agonist that promotes this receptor's activation, cannot permeate cell membranes. To develop a nanocarrier capable of achieving a high and prolonged activation over time, iE-DAP was encapsulated in nanoparticles (NPs) made of poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV). The physicochemical properties, colloidal stability, encapsulation efficiency, and cellular uptake of iE-DAP-loaded PHVB NPs were analyzed. Results evidenced that physicochemical properties of iE-DAP-loaded NPs remained stable over time, and NPs were efficiently internalized into cells, a process that depends on time and concentration. Moreover, our results showed that NPs elicited a controlled cargo release in vitro, and the encapsulated agonist response was higher than its free form, suggesting the possibility of activating intracellular receptors triggering an immune response through the release of NOD1 agonist. |
format | Online Article Text |
id | pubmed-8174487 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-81744872021-06-10 Development of a PHBV nanoparticle as a peptide vehicle for NOD1 activation Cabaña-Brunod, Mauricio Herrera, Pablo A. Márquez-Miranda, Valeria Llancalahuen, Felipe M. Duarte, Yorley González-Nilo, Danilo Fuentes, Juan A. Vilos, Cristián Velásquez, Luis Otero, Carolina Drug Deliv Research Article NOD1 is an intracellular receptor that, when activated, induces gene expression of pro-inflammatory factors promoting macrophages and neutrophils recruitment at the infection site. However, iE-DAP, the dipeptide agonist that promotes this receptor's activation, cannot permeate cell membranes. To develop a nanocarrier capable of achieving a high and prolonged activation over time, iE-DAP was encapsulated in nanoparticles (NPs) made of poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV). The physicochemical properties, colloidal stability, encapsulation efficiency, and cellular uptake of iE-DAP-loaded PHVB NPs were analyzed. Results evidenced that physicochemical properties of iE-DAP-loaded NPs remained stable over time, and NPs were efficiently internalized into cells, a process that depends on time and concentration. Moreover, our results showed that NPs elicited a controlled cargo release in vitro, and the encapsulated agonist response was higher than its free form, suggesting the possibility of activating intracellular receptors triggering an immune response through the release of NOD1 agonist. Taylor & Francis 2021-06-01 /pmc/articles/PMC8174487/ /pubmed/34060399 http://dx.doi.org/10.1080/10717544.2021.1923862 Text en © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Cabaña-Brunod, Mauricio Herrera, Pablo A. Márquez-Miranda, Valeria Llancalahuen, Felipe M. Duarte, Yorley González-Nilo, Danilo Fuentes, Juan A. Vilos, Cristián Velásquez, Luis Otero, Carolina Development of a PHBV nanoparticle as a peptide vehicle for NOD1 activation |
title | Development of a PHBV nanoparticle as a peptide vehicle for NOD1 activation |
title_full | Development of a PHBV nanoparticle as a peptide vehicle for NOD1 activation |
title_fullStr | Development of a PHBV nanoparticle as a peptide vehicle for NOD1 activation |
title_full_unstemmed | Development of a PHBV nanoparticle as a peptide vehicle for NOD1 activation |
title_short | Development of a PHBV nanoparticle as a peptide vehicle for NOD1 activation |
title_sort | development of a phbv nanoparticle as a peptide vehicle for nod1 activation |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174487/ https://www.ncbi.nlm.nih.gov/pubmed/34060399 http://dx.doi.org/10.1080/10717544.2021.1923862 |
work_keys_str_mv | AT cabanabrunodmauricio developmentofaphbvnanoparticleasapeptidevehiclefornod1activation AT herrerapabloa developmentofaphbvnanoparticleasapeptidevehiclefornod1activation AT marquezmirandavaleria developmentofaphbvnanoparticleasapeptidevehiclefornod1activation AT llancalahuenfelipem developmentofaphbvnanoparticleasapeptidevehiclefornod1activation AT duarteyorley developmentofaphbvnanoparticleasapeptidevehiclefornod1activation AT gonzaleznilodanilo developmentofaphbvnanoparticleasapeptidevehiclefornod1activation AT fuentesjuana developmentofaphbvnanoparticleasapeptidevehiclefornod1activation AT viloscristian developmentofaphbvnanoparticleasapeptidevehiclefornod1activation AT velasquezluis developmentofaphbvnanoparticleasapeptidevehiclefornod1activation AT oterocarolina developmentofaphbvnanoparticleasapeptidevehiclefornod1activation |